Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
mylan
4
×
boston blog main
life sciences
abbvie
biotech
boston top stories
epipens
gene therapy
generic drugs
national blog main
national top stories
new york blog main
new york top stories
novartis
startups
acorda therapeutics
adverum biotechnologies
albert bourla
alzheimer's disease
amgen
amicus therapeutics
ampyra
anaphylaxis
apokyn
apomorphine
arvinas
batten disease
bayer
biogen
bioinnovation capital
biolabs
boston
boulder/denver blog main
boulder/denver top stories
breast cancer
brian stuglik
cancer diagnostics
cancer immunotherapy
casimir trials
celenex
What
drug
medical
patients
acorda
acquisitions
adan
albert
anaphylactic
approved
backwards
biggest
bio
biotech
bit
bourla
bringing
called
case
ceo
company
cope
crispr
disease
driving
emergency
epi
epinephrine
episodes
fda
friday
future
gets
going
good
healthcare
help
history
imports
improved
industry
Language
unknown
unset
Current search:
mylan
×
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@techcrunch.com
6 years ago
Adan Medical is bringing technology to Epi-Pens
